Achieve recently announced that the FDA accepted its cytisinicline New Drug Application for treatment of nicotine dependence for smoking cessation, with a PDUFA target action date of June 20, 2026.

September offers a dedicated time to highlight issues and people within the recovery community and reminds others that ...

There is an urgent need for low- and middle-income countries to ensure equitable, affordable, and sustained access to tobacco-cessation medications at scale.

Lauren Ball receives funding from the National Health and Medical Research Council, Health and Wellbeing Queensland, Heart Foundation, Gallipoli Medical Research and Mater Health, Springfield City ...

The U.S. Food and Drug Administration is urging nicotine pouch manufacturers to use child-resistant packaging on their products. This comes as a rise in nicotine pouch exposure cases has been reported ...